Posted by CK Science on Thursday, 27 May 2010
As reported on the PharmaTimes, Sanofi-Aventis, a global healthcare company, has been in talks with a partner to
plan their expansion into the Japanese
generics market.
Chief Executive of Sanofi-Aventis, Chris
Viehbacher, stated: “we are interested in the Japanese generic market and we
are in a discussions with a partner but we can't officially confirm anything
because we are not quite ready for that”.
Chris Viehbacher also spoke about Sanofi"s
plans to become the fifth largest drugmaker in Japan in five years.
However, according the publication Nikkei
Business Daily, Sanofi is planning to invest $56 million for a 5% stake in
Nichi-iko. The newspaper has also reported that the two pharmaceutical
companies will form a joint venture to share technology to develop new generics
and import Sanofi products.
It is no surprise that the Japanese generics market is
becoming more and more interested in big pharma − after all, the Japanese
government has set a target to increase generics by 20% in the year to March
2013.
Looking for a job in the pharmaceutical industry?
Search
our current pharmaceutical jobs now.
|
For updates on Science Jobs, Companies, News & Career Advice, Follow us on: |
|
|
|
|
Site content copyright © 2005 - 2012. Access Job Boards Ltd all rights reserved.
